The Africa HIV Drugs Market size is estimated to grow at a CAGR of around 8.20% during the forecast period, i.e., 2024-30.                                              

Africa HIV Drugs Market Driver:

The High Rate of HIV in African Girls & Women – The epidemiological evidence suggests that the prevalence and rates of HIV are unacceptably high among women in Africa. For instance,

·        As per the Joint United Nations Programme, in 2022, adolescent girls and young women accounted for more than 77% of new infections among young people aged 15-24 years in sub-Saharan Africa.

·        The UNAIDS data also highlighted that every week, 3100 adolescent girls and young women aged 15–24 years became infected with HIV in sub-Saharan Africa in 2022.

The combination of several factors, including biological, social, behavioral, cultural, economic, and structural, in sub-Saharan Africa has led to a disparate increase in HIV infection rates among women compared to their male counterparts. Thus, the rising HIV cases further necessitate that the young girls and women in the region go for proper diagnosis and treatment for HIV to avoid adverse consequences. This has been primarily because the treatment in the form of HIV drugs belonging to different classes, such as nucleoside reverse transcriptase inhibitors (NRTIs), integrase inhibitors, protease inhibitors, etc., not only allows these women with HIV to live longer, healthier lives but also reduces the risk of further HIV transmission.

Moreover, the rising awareness among African women regarding the effects of HIV drugs and their willingness to live longer and healthier lives would further augment the size & volume of the Africa HIV Drugs Market in the coming years.

Download a free sample copy of the Report: https://www.marknteladvisors.com/query/request-sample/africa-hiv-drugs-market.html

Key Market Reports Highlights

·        Market Dimensions & Projections

·        Pricing Evaluation

·        Recent Strategic Moves by Companies

·        Primary Stakeholders

·        Import/Export Trend Analysis

·        Competitive Landscape Assessment

·        Emerging Opportunities

·        Market Trends and Indicators

*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.

Browse Full Report including (TOC+ List of Table and Figures): https://www.marknteladvisors.com/research-library/africa-hiv-drugs-market.html

Africa HIV Drugs Market Segmentation:

The market report categorizes the market based on different segments and geographical analysis.

Study Timeline:

-Base Year: 2023

-Historical Period: 2019 to 2022

-Forecast Period: 2024 to 2030

• By Drug Class
• Nucleoside Reverse Transcriptase Inhibitors (NRTIs)- Market Size & Forecast 2019-2030, USD Million
• Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)- Market Size & Forecast 2019-2030, USD Million
• Protease Inhibitors- Market Size & Forecast 2019-2030, USD Million
• Integrase Inhibitors- Market Size & Forecast 2019-2030, USD Million
• Fusion Inhibitors-Vector- Market Size & Forecast 2019-2030, USD Million
• Coreceptor Antagonists- Market Size & Forecast 2019-2030, USD Million
• Combination HIV Drugs- Market Size & Forecast 2019-2030, USD Million
• Others (Pharmacokinetic Enhancers, Capsid Inhibitors, etc.)- Market Size & Forecast 2019-2030, USD Million
• By Route of Administration
• Oral Drugs- Market Size & Forecast 2019-2030, USD Million
• Injectable Drugs- Market Size & Forecast 2019-2030, USD Million
• By Distribution Channel
• Hospital Pharmacies - Market Size & Forecast 2019-2030, USD Million
• Retail Pharmacies- Market Size & Forecast 2019-2030, USD Million
• Online Pharmacies- Market Size & Forecast 2019-2030, USD Million
• By Country
• South Africa
• Algeria
• Nigeria
• Kenya
• Uganda
• Rest of Africa

Competitive Landscape

With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market companies, including -   Aurobindo Pharma, ViiV Healthcare group of companies, Johnson & Johnson Services, Inc., Merck & Co., Inc., Cipla Inc., Bristol-Myers Squibb Company, AbbVie Inc., Gilead Sciences, Inc., Aspen Holdings, Cosmos Limited, and others,

Have questions? Our consultant is ready to assist: https://www.marknteladvisors.com/query/talk-to-our-consultant/africa-hiv-drugs-market.html

We follow a tried-and-tested research methodology that blends top-down and bottom-up approaches to deliver highly accurate market insights. Every report is powered by data triangulation, ensuring well-rounded and validated findings.

From smart sample selection and reliable data collection to in-depth analysis and precise forecasting, our process is designed to minimize error and maximize impact.

About Us –

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

Contact Us

MarkNtel Advisors

Email: sales@marknteladvisors.com

Website: www.marknteladvisors.com

Latest Press Release - https://www.marknteladvisors.com/press-release